Hone Health Secures $228 Million in Funding from MarcyPen Capital Partners
A young entrepreneur's frustration with his doctor led him to start an online clinic specializing in men's health issues, which has now secured significant funding.

A young entrepreneur's frustration with his doctor led him to start a new business, Hone Health, an online clinic specializing in men's health issues.
Saad Alam was 35 when he realized something was wrong - despite eating well and sleeping soundly, he was experiencing depression and weight gain. He sought a second opinion after being dismissed by his initial doctor with a simple diagnosis of early aging.
Alam's experience sparked the idea for Hone Health, which began treating men with low testosterone in 2020. This issue is particularly relevant to South Asian men, Alam pointed out, who often face unique health challenges.
Hone Health has now secured significant funding - $228 million in new financing was announced on Wednesday. The injection includes a $28 million equity round led by MarcyPen Capital Partners, an investment firm co-founded by Shawn "Jay-Z" Carter and Jay Brown.
The involvement of MarcyPen highlights the growing interest in healthcare startups from high-profile investors. Hone Health's announcement also reveals that MarcyPen was behind Hone's Series A funding round, a role previously unpublicized.
Hone Health's recent funding round has garnered significant attention, with MarcyPen emerging as one of its key backers.
The investment firm was formed in 2024 through a merger between Jay-Z's Marcy Venture Partners and Pendulum Holdings' investment arm. Jay Brown, speaking on behalf of MarcyPen, praised Hone's dedication to improving people's lives by making healthcare more accessible. Charlie Hanna, managing director at MarcyPen, echoed this sentiment, highlighting the company's impressive ambition and execution.
Kinship Ventures, co-founded by Gwyneth Paltrow and Moj Mahdara, is another significant investor in Hone Health's equity round. The firm has partnered with several other notable investors, including Pentland Ventures, Hanwha, Gannet Capital, and Humbition. Individual investors include the Jonas Brothers, Kelly Rowland, Marcello Hernández, David Grutman, Jason Strauss, Noah Tepperberg, and Quentin Dolan.
The involvement of these high-profile investors suggests that Hone Health's approach to healthcare is resonating with a wide range of stakeholders. Paltrow herself has been open about her positive experience with the company, citing the significant improvements she saw in her health after using their services. Her comments are a testament to the impact that Hone Health aims to have on people's lives.
The emphasis on data-driven decision-making is also a key aspect of Hone Health's approach, according to Mahdara, who notes that this will be essential for building successful healthcare companies in the future. Meanwhile, Tepperberg has spoken about his personal experience with Hone, crediting Grutman with introducing him to the company and expressing enthusiasm for referring others to their services.
Hone Health's recent funding round has attracted attention for its unconventional approach to investing in healthcare startups.
In a conversation about his personal experience with Hone, Tepperberg highlighted the company's unique services and expressed enthusiasm for referring others to their care. This sentiment is echoed by other high-profile individuals who have invested in or partnered with the company.
Longevity medicine has become a growing focus for many entrepreneurs and investors, with some dedicating decades to understanding its benefits. Strauss, co-CEO of Tao Group Hospitality, has been a long-time advocate for this approach, citing his own demanding lifestyle as motivation.
For Rowland, a key goal is empowering women to take control of their health, particularly in middle age when priorities often shift towards maintaining vitality and strength. Her comments underscore the company's commitment to holistic care and preventive medicine.
The $200 million funding package from General Catalyst's Customer Value Fund represents a significant departure from traditional venture capital models. With this deal, Hone receives upfront financing for sales and marketing efforts, which is then repaid through revenue generated by new customers.
Hone's growth has been impressive, with the company breaking through $100 million in recurring revenue last year and treating around 200,000 patients since its launch.
This milestone is a testament to Hone's innovative approach to healthcare, which has resonated with patients and investors alike. The company's patient base has consistently grown, reaching over 55,000 treated patients by January 2025.
The additional funding from General Catalyst will enable Hone to further invest in cutting-edge technology, including AI that allows a single physician to handle complex cases that would normally require multiple specialists.
As a result of this investment, Hone's total equity funding now stands at $65 million. This influx of capital will undoubtedly support the company's continued expansion and development of new services.
The company is also launching Hone Black, a concierge membership for high-profile patients, which pairs extensive health testing with a dedicated team of physicians.
Hone Health's ambitious plan to revolutionize healthcare has taken a significant leap forward with the recent investment of $228 million. This substantial funding will support the company's growth and expansion into new areas.
The clinic is designed as a last resort for patients who have exhausted all other options, Alam said, adding that even if Hone fails, its patient base can still be used to make a meaningful impact on people's lives.
Facts based on reporting originally published by Fortune.
You may republish this story, in full or in part, if you credit News Central Site and link to it (licence CC BY 4.0). Photos are not included.



